Freeman M, Parvaresh-Rizi A, Meenach S
J Drug Deliv Sci Technol. 2025; 104.
PMID: 39830679
PMC: 11737435.
DOI: 10.1016/j.jddst.2024.106535.
Gosciniak A, Laine E, Cielecka-Piontek J
Molecules. 2024; 29(22).
PMID: 39598705
PMC: 11596334.
DOI: 10.3390/molecules29225316.
Ehrenzeller S, Lukesh N, Stiepel R, Middleton D, Nuzzolo S, Tate A
RSC Pharm. 2024; 1(4):727-741.
PMID: 39415944
PMC: 11474811.
DOI: 10.1039/d4pm00054d.
Damus B, Amaeze N, Yoo E, Kaur G
Polymers (Basel). 2024; 16(19).
PMID: 39408467
PMC: 11479160.
DOI: 10.3390/polym16192756.
Ainslie K
Res Sq. 2024; .
PMID: 39399681
PMC: 11469459.
DOI: 10.21203/rs.3.rs-5024510/v1.
An aerosol nanocomposite microparticle formulation using rifampicin-cyclodextrin inclusion complexes for the treatment of pulmonary diseases.
Freeman M, Shen J, Meenach S
Int J Pharm. 2024; 665:124755.
PMID: 39321902
PMC: 11464167.
DOI: 10.1016/j.ijpharm.2024.124755.
Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicits protective immune responses against influenza viruses.
Zhang X, Shi H, Hendy D, Bachelder E, Ainslie K, Ross T
mSphere. 2024; 9(7):e0016024.
PMID: 38920382
PMC: 11288037.
DOI: 10.1128/msphere.00160-24.
Microparticles incorporating dual apoptotic factors to inhibit inflammatory effects in macrophages.
Simpson S, Middleton D, Lukesh N, Islam M, Ehrenzeller S, Bachelder E
J Pharm Sci. 2024; 113(11):3196-3205.
PMID: 38852674
PMC: 11560629.
DOI: 10.1016/j.xphs.2024.05.030.
Polymeric cGAMP microparticles affect the immunogenicity of a broadly active influenza mRNA lipid nanoparticle vaccine.
Hendy D, Ma Y, Dixon T, Murphy C, Pena E, Carlock M
J Control Release. 2024; 372:168-175.
PMID: 38844178
PMC: 11283345.
DOI: 10.1016/j.jconrel.2024.06.007.
Dynamic Release from Acetalated Dextran Nanoparticles for Precision Therapy of Inflammation.
Erensoy G, Raberg L, von Mentzer U, Menges L, Bardhi E, Hultgard Ekwall A
ACS Appl Bio Mater. 2024; 7(6):3810-3820.
PMID: 38795048
PMC: 11191005.
DOI: 10.1021/acsabm.4c00182.
Bis-2'-F-cGAMP isomers encapsulated in cytidinyl/cationic lipids act as potent in situ autologous tumor vaccines.
Yu J, Yu X, Sun X, Wang Q, Long S, Ren R
Mol Ther. 2024; 32(6):1917-1933.
PMID: 38637990
PMC: 11184333.
DOI: 10.1016/j.ymthe.2024.04.023.
Polymeric Nanoparticles for Drug Delivery.
Beach M, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y
Chem Rev. 2024; 124(9):5505-5616.
PMID: 38626459
PMC: 11086401.
DOI: 10.1021/acs.chemrev.3c00705.
Structural Determinants of Stimuli-Responsiveness in Amphiphilic Macromolecular Nano-assemblies.
Liu H, Lu H, Alp Y, Wu R, Thayumanavan S
Prog Polym Sci. 2024; 148.
PMID: 38476148
PMC: 10927256.
DOI: 10.1016/j.progpolymsci.2023.101765.
Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicit protective immune responses against influenza viruses.
Zhang X, Shi H, Hendy D, Bachelder E, Ainslie K, Ross T
bioRxiv. 2024; .
PMID: 38464191
PMC: 10925245.
DOI: 10.1101/2024.02.27.582355.
Development of Aerosol Dry Powder Chemotherapeutic-Loaded Microparticles for the Treatment of Lung Cancer.
Ivone R, Karabots A, Meenach S
AAPS PharmSciTech. 2024; 25(3):42.
PMID: 38366056
DOI: 10.1208/s12249-024-02751-8.
Dextran-based Drug Delivery Approaches for Lung Diseases: A Review.
Kumari M, Sharma S, Kanwar N, Naman S, Baldi A
Curr Drug Deliv. 2024; 21(11):1474-1496.
PMID: 38243938
DOI: 10.2174/0115672018267737231116100812.
Flash nanoprecipitation allows easy fabrication of pH-responsive acetalated dextran nanoparticles for intracellular release of payloads.
Hughes K, Misra B, Maghareh M, Samart P, Nguyen E, Hussain S
Discov Nano. 2024; 19(1):4.
PMID: 38175336
PMC: 10766584.
DOI: 10.1186/s11671-023-03947-w.
Photoacid Generators for Biomedical Applications.
Sun T, Kang L, Zhao H, Zhao Y, Gu Y
Adv Sci (Weinh). 2023; 11(5):e2302875.
PMID: 38039443
PMC: 10837391.
DOI: 10.1002/advs.202302875.
Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease.
De Rubis G, Paudel K, Corrie L, Mehndiratta S, Patel V, Kumbhar P
Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(5):2793-2833.
PMID: 37991539
DOI: 10.1007/s00210-023-02830-w.
Cell and biomaterial delivery strategies to induce immune tolerance.
Scotland B, Shaw J, Dharmaraj S, Caprio N, Cottingham A, Lasola J
Adv Drug Deliv Rev. 2023; 203:115141.
PMID: 37980950
PMC: 10842132.
DOI: 10.1016/j.addr.2023.115141.